You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Direct Acting Oral Anticoagulants

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DOAC ADRs Retrospective Study

Terminated
  • Drug-Related Side Effects and Adverse Reactions
    • San Jose, California
      Santa Clara Valley Medical Center
    Mar 4, 2021

    Pharmacodynamics of Direct Oral Anticoagulants

    Unknown status
    • Novel Oral Anticoagulants
    • +8 more
    • detection of genotype
    • Hefei, Anhui, China
    • +16 more
    Dec 19, 2020

    Severe Bleeding, Urgent Surgery Trial (Urgent surgery which can not be postponed to the next 24 hrs)

    Withdrawn
    • Severe Bleeding
    • Urgent Surgery
    • Urgent surgery which can not be postponed to the next 24 hrs
    • (no location specified)
    Jul 15, 2020

    Specific PoC Testing of Coagulation in Patients Treated With

    Recruiting
    • Anticoagulation With NOAC
    • anti-Xa activity point-of-care testing (aXa-POCT)
    • ecarin clotting time point-of-care testing (ECT-POCT)
    • Tuebingen, Germany
      University Hospital Tuebingen
    Dec 14, 2020

    Direct Oral Anticoagulants in Ph-negative Myeloproliferative

    Completed
    • Myeloproliferative Neoplasm
    • New York, New York
    • +17 more
    Feb 19, 2021

    Severe Uterine Bleeding Following Exposure to Direct Oral

    Completed
    • Uterine Hemorrhage
    • Titusville, New Jersey
      Janssen R&D
    Jun 10, 2020

    Hepatitis C Infection Trial in United States (MBL-HCV1, Telaprevir (Part 1), Sofosbuvir (Part 2))

    Terminated
    Has Results
    • Hepatitis C Infection
    • MBL-HCV1
    • +2 more
    • Boston, Massachusetts
    • +4 more
    Feb 4, 2021

    Atrial Fibrillation, Venous Thromboembolism Trial in Hamilton (RABEprazole 20 Mg Oral Delayed Release Tablet, APO-Dabigatran

    Completed
    • Atrial Fibrillation
    • Venous Thromboembolism
    • RABEprazole 20 Mg Oral Delayed Release Tablet
    • APO-Dabigatran 150mg
    • Hamilton, Ontario, Canada
      The Population Health Research Institute
    Mar 18, 2022

    Bleeding Post Cardiac Surgery, Indication for Anticoagulation Trial in Hamilton (DOAC, VKA)

    Recruiting
    • Bleeding Post Cardiac Surgery
    • Indication for Anticoagulation
    • Hamilton, Ontario, Canada
      Hamilton General Hospital
    Oct 31, 2022

    New Oral Anticoagulants in Treatment of Non-valvular Atrial

    Recruiting
    • Atrial Fibrillation
    • Burgos, Spain
    • +5 more
    Jan 2, 2023

    Use of Direct Oral Anticoagulants in UK

    Completed
    • Stroke
    • Rivaroxaban (Xarelto, BAY59-7939)
    • +2 more
    • Multiple Locations, United Kingdom
      Many Locations
    Apr 16, 2020

    Interference Between Oral Anticoagulants and Heparin During

    Recruiting
    • Atrial Fibrillation
    • Atrial Tachycardia
      • Paris, France
        Hopital Bichat-Claude Bernard
      Mar 27, 2023

      Splanchnic Vein Thrombosis, Cerebral Vein Thrombosis, Ovarian Vein Thrombosis Trial in Varese (Direct Oral Anticoagulants)

      Unknown status
      • Splanchnic Vein Thrombosis
      • +4 more
      • Direct Oral Anticoagulants
      • Varese, Italy
        University of Insubria
      Apr 30, 2020

      Polypharmacy, Insomnia, Anticoagulants Trial in Ann Arbor (Academic Detailing (AD), LEAP)

      Recruiting
      • Polypharmacy
      • +2 more
      • Academic Detailing (AD)
      • LEAP
      • Ann Arbor, Michigan
        VA Ann Arbor Healthcare System, Ann Arbor, MI
      Jul 18, 2022

      Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments

      Completed
      • Hemophilia A
      • +2 more
      • Vitamin K Antagonist - Drug
      • Brest, France
      • +5 more
      Apr 6, 2023

      Deep Vein Thrombosis, Post Thrombotic Syndrome Trial in Hamilton, Toronto (tinzaparin, Rivaroxaban)

      Recruiting
      • Deep Vein Thrombosis
      • Post Thrombotic Syndrome
      • Hamilton, Ontario, Canada
      • +2 more
      May 4, 2022

      Rivaroxaban and Apixaban in Cancer Patients

      Recruiting
      • Anticoagulants and Thrombotic Disorders
      • Monitoring
      • Paris, France
        Centre d'Investigation Clinique Hôpital Pitié-Salpêtrière
      Apr 20, 2023

      Different Antithrombotic Therapy for Treatment of Ventricular

      Recruiting
      • Ventricular Thrombus
      • non-vitamin K antagonist oral anticoagulants (NOACs)
      • +3 more
      • Beijing, China
        Qing Yang
      Jul 11, 2022

      Intracerebral Hemorrhage Trial in Basel (Tranexamic acid, Saline 0.9%)

      Completed
      • Intracerebral Hemorrhage
      • Tranexamic acid
      • Saline 0.9%
      • Basel, Switzerland
        Stroke Center, University Hospital Basel
      Mar 22, 2022

      Hepatitis C Trial (Zinc Supplement)

      Not yet recruiting
      • Hepatitis C
      • Zinc Supplement
      • (no location specified)
      Jul 16, 2022

      Ptsd Trial in White River Junction (Glecaprevir/pibrentasvir, Placebo)

      Not yet recruiting
      • Ptsd
      • White River Junction, Vermont
        White River Junction VAMC
      Dec 12, 2022

      Atrial Fibrillation, Peritoneal Dialysis Complication Trial (Anticoagulation Agents)

      Not yet recruiting
      • Atrial Fibrillation
      • Peritoneal Dialysis Complication
      • Anticoagulation Agents
      • (no location specified)
      Sep 13, 2023

      HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)

      Recruiting
      • HIV-1-infection
      • Kisumu, Kenya
      • +6 more
      Feb 1, 2023

      Sonoclot to Evaluate Thrombotic Risk in Proteinuric Pregnancy

      Not yet recruiting
      • Pregnancy Complications
      • +3 more
      • Viscoelastic haemostasis monitor output
      • (no location specified)
      Oct 25, 2021

      Oral Anti-coagulants in Fragile Percutaneous Endoscopic

      Completed
      • Atrial Fibrillation
      • Rome, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Oct 25, 2021